<DOC>
	<DOCNO>NCT00762034</DOCNO>
	<brief_summary>This study compare overall survival participant Stage IIIB IV nonsquamous non-small cell lung cancer .</brief_summary>
	<brief_title>A Study Pemetrexed , Carboplatin Bevacizumab Participants With Nonsquamous Non-Small Cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Pemetrexed</mesh_term>
	<criteria>You must sign informed consent document clinical research . You must Stage IIIB Stage IV nonsquamous nonsmall cell lung cancer . You must receive prior treatment disease . Prior radiation therapy allow &lt; 25 % bone marrow ; however , prior radiation whole pelvis allow . If radiation therapy chest , eligible participate . You must least 18 year age old . You must measureable tumor lesion accord Response Evaluation Criteria Solid Tumors ( RECIST ) disease evaluate computed tomography ( CT ) scan . Your test result assess function blood form tissue , kidneys liver must satisfactory . Women must sterile , postmenopausal contraception men must sterile ( example postvasectomy ) contraception . You clinically significant thirdspace fluid collection ( e.g . ascites pleural effusion control drainage procedure ) . You Nonsmall Cell Lung Carcinoma ( NSCLC ) predominantly squamous cell histology . You known central nervous system ( CNS ) disease , stable , treated brain metastasis . You undergone surgical procedure , open biopsy , open pleurodesis , significant traumatic injury within 28 day start study treatment , anticipate need major surgery study . You history gastrointestinal fistula , perforation , abscess , inflammatory bowel disease , diverticulitis . You currently receive ongoing treatment fulldose warfarin equivalent . You significant vascular disease , serious cardiac condition ( heart attack ) , stroke transient ischemic attack within 6 month trial . You evidence bleed diathesis coagulopathy ( absence therapeutic anticoagulation ) . You inadequately control hypertension , history hypertensive crisis hypertensive encephalopathy . You serious , nonhealing wound , active ulcer , untreated bone fracture . You another form cancer , superficial basal cell superficial squamous ( skin ) cell , carcinoma situ cervix within last 5 year . You receive investigational treatment within 30 day prior trial . You previously receive treatment paclitaxel , carboplatin , pemetrexed , bevacizumab . You pregnant breastfeed . You know sensitivity component paclitaxel , carboplatin , pemetrexed , bevacizumab . You history hemoptysis ( cough blood ) within 3 month prior trial . You unable stop take aspirin 1.3 gram per day nonsteroidal antiinflammatory drug ( NSAIDs ) . You unable unwilling take folic acid vitamin B12 supplementation . You unable take corticosteroid . You ongoing illness include active infection may allow adhere requirement trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>